A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations (TRUST)

Astellas

Status: Completed

Conditions: Lupus Nephritis

Treatments: Drug: Tacrolimus

Study type: Observational

Funder types: Industry

Identifiers

NCT01410747

PRGN01

Details and patient eligibility

About

To evaluate the safety and efficacy of tacrolimus for lupus nephritis under actual-use.

Full description

The objectives of the survey are to evaluate the safety and efficacy of tacrolimus for lupus nephritis under actual-use situations, and to identify factors that might affect the safety and efficacy of tacrolimus. In addition, long-term renal outcome will be evaluated.

Enrollment: 1,484 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

patients receiving tacrolimus for the treatment of lupus nephritis

Trial design

1,484 participants in 1 patient group

tacrolimus group

Description:

Oral

Treatment:

Drug: Tacrolimus